Form 8-K - Current report:
SEC Accession No. 0001193125-24-233038
Filing Date
2024-10-04
Accepted
2024-10-04 16:01:59
Documents
15
Period of Report
2024-10-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d828798d8k.htm   iXBRL 8-K 25340
2 EX-99.1 d828798dex991.htm EX-99.1 8856
6 GRAPHIC g828798g1004111012156.jpg GRAPHIC 2526
  Complete submission text file 0001193125-24-233038.txt   163141

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idya-20241004.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20241004_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20241004_pre.xml EX-101.PRE 11266
17 EXTRACTED XBRL INSTANCE DOCUMENT d828798d8k_htm.xml XML 3652
Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 241354871
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)